• OPEN AN ACCOUNT
Indian Indices
Sensex
77,540.83 3.11
( 0.00%)
Global Indices
Nasdaq
53,294.39 514.18
(0.97%)
Dow Jones
7,693.51 31.35
(0.41%)
Hang Seng
65,893.13 -323.66
(-0.49%)
Nikkei 225
10,809.01 60.85
(0.57%)
Forex
USD-INR
95.67 0.05
(0.05%)
EUR-INR
111.76 0.57
(0.51%)
GBP-INR
130.35 0.55
(0.42%)
JPY-INR
0.60 0.00
(0.11%)

EQUITY - MARKET SCREENER

IFL Enterprises Ltd
Industry :  Trading
BSE Code
ISIN Demat
Book Value()
540377
INE714U01024
0.9975904
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
42.33
EPS(TTM)
Face Value()
Div & Yield %
0
1
0
 

emco ltd
Lupin receives USFDA approval for Pitolisant Tablets, 4.45 mg and 17.8 mg
Aug 17,2026
Lupin has received the final approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application for Pitolisant Tablets, 4.45 mg and 17.8 mg.

The U.S. FDA has approved Lupin's Pitolisant Tablets, 4.45 mg and 17.8 mg, as bioequivalent to Wakix® for the indications in the approved labeling.